These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8508555)

  • 1. IgM rheumatoid factor and the inhibition of covalent binding of C4b to IgG in immune complexes.
    Jarvis JN; Lockman JC; Levine RP
    Clin Exp Rheumatol; 1993; 11(2):135-41. PubMed ID: 8508555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM-RF prevents complement-mediated inhibition of immune precipitation.
    Mitchell WS; Naama JK; Veitch J; Whaley K
    Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 19S IgM rheumatoid factor-7S IgG rheumatoid factor immune complexes isolated in patients with rheumatoid arthritis.
    Moore TL; Dorner RW; Zuckner J
    J Lab Clin Med; 1986 May; 107(5):465-70. PubMed ID: 3701193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of Clq binding activity by IgM rheumatoid factor.
    Zilberfarb JL; Andrews BS; Young AC; Davis JS
    J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
    O'Sullivan MM; Amos N; Williams BD
    Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis?
    Fornasieri A; Armelloni S; Bernasconi P; Li M; de Septis CP; Sinico RA; D'Amico G
    Am J Kidney Dis; 1996 Apr; 27(4):476-83. PubMed ID: 8678056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G; Schouten J; Cats A; Daha MR
    Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The isolation of immune complexes containing IgM rheumatoid factor and recovery of IgG rheumatoid factor from the complexes.
    Jones VE; Cowley PJ; Allen C; Elson CJ
    J Immunol Methods; 1980; 37(1):1-14. PubMed ID: 6776201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies.
    Laurent L; Anquetil F; Clavel C; Ndongo-Thiam N; Offer G; Miossec P; Pasquali JL; Sebbag M; Serre G
    Ann Rheum Dis; 2015 Jul; 74(7):1425-31. PubMed ID: 24618262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of covalent complexes between the fourth component of human complement and IgG immune aggregates.
    Alcolea JM; Antón LC; Marqués G; Sánchez-Corral P; Vivanco F
    Complement; 1987; 4(1):21-32. PubMed ID: 3568629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
    Wagner T; Abraham G; Baum J
    J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid factors in the pathogenesis of rheumatoid arthritis.
    Mannik M
    J Rheumatol Suppl; 1992 Jan; 32():46-9. PubMed ID: 1613732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG and IgM rheumatoid factor in active seronegative nodular rheumatoid arthritis and in children with benign rheumatoid nodules.
    Robbins DL; Moore TL; Naguwa SM
    Clin Rheumatol; 1982 Jun; 1(2):104-11. PubMed ID: 6926807
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissociation of soluble antigen-antibody complexes by rheumatoid factor IgM.
    Alkner U
    Scand J Immunol; 1983 Aug; 18(2):131-6. PubMed ID: 6224291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationised IgM rheumatoid factor: in-vivo glomerular localization and immunoabsorptive capacity in the mouse.
    Ford PM; Kosatka I
    Clin Exp Immunol; 1985 Oct; 62(1):150-8. PubMed ID: 3905095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
    Lorber M; Samuel D; Amlot P; Panayi GS
    Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.